News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Hilary Robbins Presented at the G7 Cancer Conference on Poor Prognosis Cancers – IARC
IARC-WHO/LinkedIn
Jun 27, 2025, 05:19

Hilary Robbins Presented at the G7 Cancer Conference on Poor Prognosis Cancers – IARC

IARC – International Agency for Research on Cancer / World Health Organization shared a post on LinkedIn:

” ‘Lung Cancer has the epidemiological fingerprint of a ‘screenable’ cancer type’
IARC’s Dr Hilary Robbins presented at the G7 Cancer Conference on Poor Prognosis Cancers, organized by the French National Cancer Institute (Institut national du cancer) and NCC Japan, in Paris, with IARC Director Dr Elisabete Weiderpass and other IARC scientists in attendance.”

G7 Cancer Conference

More posts featuring IARC on OncoDaily.

cancer Elisabete Weiderpass G7 Cancer Conference Hilary Robbins IARC International Agency for Research on Cancer / World Health Organization Lung cancer NCC Japan OncoDaily Oncology Poor Prognosis Cancers
Special Coverage
Voices
Aug 28, 2025, 16:47
Dual-Antigen Targeting CART-Cells - Resonance
Science
Aug 28, 2025, 16:47
Roberto Borea Highlight Multi-Omic Approach to NSCLC Diagnostics
Voices
Aug 28, 2025, 16:40
Voices of the Families: The 7-Year-Old Girl from Limmu Kosa - CANCaRe Africa
Trial Updates
Aug 28, 2025, 16:14
Paolo Tarantino: Abemaciclib Improves Survival in High-Risk HR Positive HER2 Negative Breast Cancer
Insight
Aug 28, 2025, 16:12
Redefining Precision Medicine Beyond Oncology with AI and Real-World Data - Amgen
Voices
Aug 28, 2025, 16:10
Special Message from JPORP Advisory Board Member Clarissa Schilstra - IPOS
Radiotherapy
Aug 28, 2025, 16:02
Jeff White: Shining a Light on World Radiation Therapy Awareness Day
Insight
Aug 28, 2025, 15:59
Primoz Petric: INTERLACE - Not a New Standard for Cervical Cancer Chemoradiation
Trial Updates
Aug 28, 2025, 15:56
Raul Cordoba: COVID-19 and Bispecific Antibodies in Blood Cancer
Trial Updates
Aug 28, 2025, 15:55
David Heredia: LEOPARD Study Highlights Early NSCLC Recurrence
Trial Updates
Aug 28, 2025, 15:55
ANKTIVA NK Cell Therapy Shows 100 Percent Disease Control in Recurrent Glioblastoma - ImmunityBio
Insight
Aug 28, 2025, 15:54
Bishal Gyawali: Inferior Control Arms in LMIC Oncology Trials in a New BMJ Oncology Editorial